Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126843391 | 12684339 | 1 | I | 20160816 | 20160825 | 20160825 | EXP | SE-MPA-2016-004492 | SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-067527 | BRISTOL MYERS SQUIBB | 90.00 | YR | F | Y | 0.00000 | 20160825 | CN | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126843391 | 12684339 | 1 | PS | ELIQUIS | APIXABAN | 1 | Unknown | Y | U | 202155 | |||||||||
| 126843391 | 12684339 | 2 | SS | MICARDIS | TELMISARTAN | 1 | Unknown | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126843391 | 12684339 | 1 | Cerebrovascular accident prophylaxis |
| 126843391 | 12684339 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126843391 | 12684339 | OT |
| 126843391 | 12684339 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126843391 | 12684339 | Formication | |
| 126843391 | 12684339 | Gastrointestinal haemorrhage | |
| 126843391 | 12684339 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126843391 | 12684339 | 1 | 201606 | 0 | ||
| 126843391 | 12684339 | 2 | 201606 | 0 |